// App-Quantinova.ai

[THU0400] : RESPONSE TO ECULIZUMAB IN THE ANTIPHOSPHOLIPID ANTIBODY SYNDROME

Researchers

Presenter

  • E. Zapantis

Principal Investigators

  • R. Furie

  • D. Horowitz

Medical Centers

  • North Shore-Long Island Jewish Health Systems, Manhasset, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Antiphospholipid syndrome

  • Lupus

  • Renal disease

  • Venous thrombosis

  • Inflammatory Arthritis

Biomarkers

  • Complement Component 5a

  • Immunoglobulin G

Drug/Treatment

  • Eculizumab

  • Immunol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved